Expectant management of very low-, low-risk prostate cancer is effective, but underused
the ONA take:
Using watchful waiting or active surveillance to monitor men with very low- and low-risk prostate cancer is effective in many patients with localized tumors and could prevent aggressive and unnecessary treatments, according to a new study published in CA: A Cancer Journal for Clinicians.
Researchers from the University of California, Los Angeles, conducted a review of expectant management in men with very low- and low-risk prostate cancer. Active surveillance utilizes repeated testing of PSA and prostate biopsies to monitor for cancer progression. Those who are younger and healthier may benefit most from delaying treatment for the disease. On the other hand, watchful waiting monitors for physical symptoms of disease progression and avoids repeated testing. This option is typically best for those who are older and sicker and will likely die from another cause.
"Active surveillance and other observational strategies have produced excellent, long-term disease-specific survival and minimal morbidity for men with prostate cancer. Despite this, expectant management remains underused for men with localized prostate cancer," review senior author Dr. Mark Litwin, professor and chair of UCLA Urology said
Using expectant management to monitor men with very low- and low-risk prostate cancer is effective in many patients with localized tumors.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Prognostic Factors for Survival Among Patients With Primary Bone Sarcomas of Small Bones
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- A Call for More Tailored Cancer Education Programs to Improve Screening
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|